Endothelium-Derived Vasodilators in Pregnancy
妊娠期内皮衍生血管扩张剂
基本信息
- 批准号:7880324
- 负责人:
- 金额:$ 1.83万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1993
- 资助国家:美国
- 起止时间:1993-07-01 至 2012-05-31
- 项目状态:已结题
- 来源:
- 关键词:1-Phosphatidylinositol 3-KinaseAddressAgonistArteriesBirth WeightBlood flowCell CommunicationCell Culture TechniquesCell LineCell SeparationCell modelCellsCouplingDataDiseaseEmployee StrikesEndothelial CellsEndotheliumEstrogen ReceptorsEstrogensFetal GrowthFetal Growth RetardationFunctional disorderGene ExpressionGenomicsImageIn VitroLonomycinLuteal PhaseMAP Kinase GeneMAPK Signaling Pathway PathwayMeasuresMediatingMicroscopeMitogen Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3ModelingMolecularNitric OxideOvarianPathway interactionsPhosphorylation InhibitionPhosphotransferasesPhysiologicalPlayPre-EclampsiaPregnancyPrincipal InvestigatorProductionProto-Oncogene Proteins c-aktRecruitment ActivityRoleSheepSignal PathwaySignal TransductionSlideThird Pregnancy TrimesterTimeVasodilationVasodilator AgentsWomanbasecell growth regulationfetalin vitro Modelin vivonon-genomicnovelphysiologic modelpregnantprogramsproliferative phase Menstrual cycleresponseresponse markershear stress
项目摘要
Interactions between estrogen and NO to regulate UBF at the maternal-fetal placental interface are critically
important to fetal growth. Pregnant (P) and Follicular (Fol)Nonpregnant (NP)Uterine Artery Endothelial Cells
(UAEC) undergo adaptation compared to Luteal (Lut) NP-UAEC; i.e. responses seen in freshly isolated UA
Endothelium maintaining upon numerous passages. These include ERK 1/2 -MAPK coupling to eNOS activation
for substantial ATP-stimulated NO production (P > Fol-NP> Lut-NP) and the role estrogen may have to alter Ca2+
mediated NO. Shear stress and/or estrogen are both very potent stimulators of NO synthesis and/or eNOS
expression and together they elicit synergistic activation of the ERK 1/2 MAPK signaling pathway in P-UAEC.
Elevations in blood flow also substantially increase the laminar shear stress. Other signaling pathways (e.g. PI3
Kinase) may play an additional convergent role in the in vivo situation. Overall hypothesis: Physiologic states of
High DBF/shear stress and elevated estrogen (e.g. P and Fol) causes "Programmed Adaptation" of the UAEC to
modulate important endothelial functions associated with NO production. Specific emphasis is given to
mechanisms that increase eNOS activation, eNOS expression, UAEC signaling kinases (e.g. ERK 1/2 and/or. PIS
Kinase), and cell-cell communication (measured as synchronized Ca2+ bursts).
Aim I- Physiologic Models: Using In V/Vo-derived freshly isolate UA Endothelium (Passage 0) from Pregnant,
Cycling (Foland Lut)and Ovariectomized (Vehicle vs Estrogen-treated) sheep, studies will be performed
evaluating cellular regulation (nongenomic and genomic) by which Estrogen alters basal, ATP and lonomycin
eNOS activation by directly imaging intracellular NO production simultaneously with [Ca2+]i/Ca2+ bursts and
evaluating the role of ERs and converging signaling intermediate (ERK1/2 MAPK and/or PIS Kinase) pathways.
Aim II- Shear Stress Models: Effects of prolonged Laminar Shear Stress [0 (static), 3 & 15 dynes/cm2] with and
without E2(3on "Programmed UAEC Adaptation" of long term cultured (Passage 4-5) Lut NP-UAEC, Fol NP-
UAEC, and P-UAEC. The specific markers of adaptation that are "programmed" from the time isolation we focus
on include: a) eNOS expression and ATP/lonomycin-stimulated eNOS activation and [Ca2+]i/Ca2+ bursts and b)
ATP/lonomycin-stimulated ERK1/2 and AKT phosphorylation; and inhibition of ERK-MAPK and/or PIS Kinase
mediated stimulated NO production and [Ca2+]i/Ca2+ bursts. We hypothesize that inclusion of both shear stress
and estrogen will be necessary to restore the specific markers and response magnitude "programmed" into
UAECs by high flow and estrogen during Pregnancy and in the Follicular phase defined in Aim I. Data thus
derived will provide the first mechanistic framework for understanding interactions between shear stress and
estrogen to regulate UAEC NO and converging signaling mechanisms this. Our recent preliminary data
demonstrates that uterine artery shear stress is indeed reduced in pregnancies complicated by preeclampsia.
Therefore these mechanisms are likely also to be dysfunctional during preeclampsia with or without IUGR.
雌激素和 NO 之间的相互作用对于调节母胎胎盘界面的 UBF 至关重要
对胎儿生长很重要。妊娠 (P) 和滤泡 (Fol) 非妊娠 (NP) 子宫动脉内皮细胞
(UAEC) 与黄体 (Lut) NP-UAEC 相比经历了适应;即在新分离的 UA 中看到的反应
内皮维持在许多通道上。其中包括 ERK 1/2 -MAPK 与 eNOS 激活的偶联
大量 ATP 刺激的 NO 产生 (P > Fol-NP> Lut-NP) 以及雌激素可能改变 Ca2+ 的作用
介导的NO。剪切应力和/或雌激素都是 NO 合成和/或 eNOS 的非常有效的刺激剂
表达并共同引发 P-UAEC 中 ERK 1/2 MAPK 信号通路的协同激活。
血流的升高也会大大增加层流剪切应力。其他信号通路(例如 PI3
激酶)可能在体内情况中发挥额外的收敛作用。总体假设:生理状态
高 DBF/剪切应力和升高的雌激素(例如 P 和 Fol)导致 UAEC 的“程序性适应”
调节与 NO 产生相关的重要内皮功能。具体强调的是
增加 eNOS 激活、eNOS 表达、UAEC 信号激酶(例如 ERK 1/2 和/或 PIS)的机制
激酶)和细胞间通讯(以同步 Ca2+ 爆发来测量)。
目标 I-生理模型:使用来自孕妇的 V/Vo 衍生的新鲜分离的 UA 内皮细胞(第 0 代),
将进行骑自行车(Foland Lut)和卵巢切除(车辆与雌激素处理)羊的研究
评估雌激素改变基础、ATP 和龙霉素的细胞调节(非基因组和基因组)
通过直接成像细胞内 NO 生成与 [Ca2+]i/Ca2+ 爆发同时进行 eNOS 激活
评估 ER 和汇聚信号中间体(ERK1/2 MAPK 和/或 PIS 激酶)途径的作用。
目标 II - 剪切应力模型:长期层流剪切应力 [0(静态)、3 和 15 达因/cm2] 的影响
没有E2(3关于长期培养的“程序化UAEC适应”(第4-5代)Lut NP-UAEC,Fol NP-
UAEC 和 P-UAEC。从我们关注的时间隔离中“编程”的具体适应标记
包括:a) eNOS 表达和 ATP/lonomycin 刺激的 eNOS 激活和 [Ca2+]i/Ca2+ 爆发和 b)
ATP/lonomycin 刺激 ERK1/2 和 AKT 磷酸化;以及 ERK-MAPK 和/或 PIS 激酶的抑制
介导刺激 NO 产生和 [Ca2+]i/Ca2+ 爆发。我们假设包含剪切应力
雌激素对于恢复特定标记和“编程”到的反应幅度是必要的
怀孕期间和目标 I 中定义的卵泡期通过高流量和雌激素产生的 UAEC。数据如下
推导将为理解剪切应力和剪切应力之间的相互作用提供第一个机械框架
雌激素调节 UAEC NO 和聚合信号机制。我们最近的初步数据
表明在并发先兆子痫的妊娠中,子宫动脉剪切应力确实降低了。
因此,这些机制在有或没有 IUGR 的先兆子痫期间也可能出现功能障碍。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RONALD R MAGNESS其他文献
RONALD R MAGNESS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RONALD R MAGNESS', 18)}}的其他基金
Endothelial Function in a Model of IUGR Induced by Uterine Space Restriction
子宫空间限制引起的 IUGR 模型中的内皮功能
- 批准号:
8639270 - 财政年份:2013
- 资助金额:
$ 1.83万 - 项目类别:
Endothelial Function in a Model of IUGR Induced by Uterine Space Restriction
子宫空间限制引起的 IUGR 模型中的内皮功能
- 批准号:
8851181 - 财政年份:2013
- 资助金额:
$ 1.83万 - 项目类别:
Endothelial Function in a Model of IUGR Induced by Uterine Space Restriction
子宫空间限制引起的 IUGR 模型中的内皮功能
- 批准号:
8786597 - 财政年份:2013
- 资助金额:
$ 1.83万 - 项目类别:
Physiologic Cardiovascular & Uterine eNOS Responses:Role of Endogenous Estrogen
生理心血管
- 批准号:
7499532 - 财政年份:2007
- 资助金额:
$ 1.83万 - 项目类别:
Physiologic Cardiovascular & Uterine eNOS Responses:Role of Endogenous Estrogen
生理心血管
- 批准号:
7635379 - 财政年份:2007
- 资助金额:
$ 1.83万 - 项目类别:
Physiologic Cardiovascular & Uterine eNOS Responses:Role of Endogenous Estrogen
生理心血管
- 批准号:
7322457 - 财政年份:2007
- 资助金额:
$ 1.83万 - 项目类别:
Physiologic Cardiovascular & Uterine eNOS Responses:Role of Endogenous Estrogen
生理心血管
- 批准号:
7663772 - 财政年份:2007
- 资助金额:
$ 1.83万 - 项目类别:
Physiologic Cardiovascular & Uterine eNOS Responses:Role of Endogenous Estrogen
生理心血管
- 批准号:
7898863 - 财政年份:2007
- 资助金额:
$ 1.83万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 1.83万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 1.83万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 1.83万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 1.83万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 1.83万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 1.83万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 1.83万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 1.83万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 1.83万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 1.83万 - 项目类别:
Research Grant














{{item.name}}会员




